Patricia Lorenzo-Luaces

A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients

Pedro C. Rodríguez, Xitllaly Popa, Odeth Martínez et al. · Clinical Cancer Research · 2016 · 166 citations

Medicine, Immunology, Oncology +17

Biomarkers related to immunosenescence: relationships with therapy and survival in lung cancer patients

Danay Saavedra, Beatriz García Verdecia, Patricia Lorenzo-Luaces et al. · Cancer Immunology Immunotherapy · 2015 · 74 citations · Full text

Medicine, Immunology, Oncology +12

Treatment of malignant, non-resectable, epithelial origin esophageal tumours with the humanized anti-epidermal growth factor antibody nimotuzumab combined with radiation therapy and chemotherapy.

Mayra Ramos, Patricia Lorenzo-Luaces, N González Lazo et al. · Cancer Biology & Therapy · 2012 · 69 citations · Full text

Medicine, Oncology, Pharmacology +17

Repair of UVB-Damaged Skin by the Antioxidant Sulphated Flavone Glycoside Thalassiolin B Isolated from the Marine Plant Thalassia testudinum Banks ex König

Erik L. Regalado, María Rodríguez-Pérez, Roberto Menéndez et al. · Marine Biotechnology · 2008 · 48 citations

Life Sciences, Botany, Plant Sciences +14

Blocking Egfr with Nimotuzumab: A Novel Strategy for Covid-19 Treatment

Henrry Diaz Londres, Jorge Jiménez Armada, Aray Hernández Martínez et al. · Immunotherapy · 2022 · 42 citations

Life Sciences, Immunology, Pharmacotherapy +17